Doctor profile · Federal record
Dr. Evelyn Mendoza, M.D.
Specialist (CMS: Hematology/Oncology) · Hemet, CA
- NPI 1558368605
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 42 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
301 N San Jacinto St
Hemet, CA 925433113
(951) 766-6460
fax (951) 766-6459 - Mailing address
-
23278 Kent CT
Murrieta, CA 925625086
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- February 5, 2009
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- California #A48611
- Medicaid
- CA #00A486110
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558368605. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
321,407
Distinct HCPCS
10
Medicare allowed
$4,078,733
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 133,500 | 113 | $1 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 19,360 | 84 | $7 | |
J0897 |
Injection, denosumab, 1 mg | 17,580 | 91 | $21 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 15,480 | 23 | $47 | |
J9025 |
Injection, azacitidine, 1 mg | 15,400 | 11 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 14,790 | 19 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 13,400 | 19 | $54 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 11,200 | 12 | $0 | |
J9119 |
Injection, cemiplimab-rwlc, 1 mg | 10,850 | 11 | $27 | |
J1556 |
Injection, immune globulin (bivigam), 500 mg | 8,110 | 27 | $71 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 3,170. This provider delivers 101× the peer median.Open Payments
Industry payments received
All-time total
$4,683
Transactions
132
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $1,492.70 | |
| Janssen Biotech, Inc. | 17 | $300.80 | |
| Daiichi Sankyo Inc. | 9 | $253.05 | |
| Merck Sharp & Dohme LLC | 10 | $248.77 | |
| E.R. Squibb & Sons, L.L.C. | 15 | $235.94 | |
| PFIZER INC. | 9 | $190.98 | |
| AstraZeneca Pharmaceuticals LP | 7 | $172.11 | |
| SOBI, INC | 5 | $152.06 | |
| ABBVIE INC. | 5 | $124.62 | |
| Celgene Corporation | 4 | $117.59 | |
| BeiGene USA, Inc. | 4 | $114.16 | |
| Eisai Inc. | 5 | $105.33 | |
| Alexion Pharmaceuticals, Inc. | 3 | $87.05 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86.60 | |
| Incyte Corporation | 4 | $81.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
799
Patients
205
Total drug cost
$1,933,117
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 169 | 48 | $4,995 |
| Dexamethasone | Generic | 96 | 28 | $1,585 |
| Acyclovir | Generic | 73 | 19 | $1,200 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 65 | 0 | $1,178,246 |
| Letrozole | Generic | 53 | 18 | $2,140 |
| Potassium Chloride | Generic | 46 | 12 | $711 |
| Ondansetron Hcl | Generic | 44 | 29 | $411 |
| Prochlorperazine Maleate | Generic | 38 | 24 | $429 |
| Hydroxyurea | Generic | 37 | 0 | $1,971 |
| Revlimid (Lenalidomide) | Brand | 35 | 0 | $716,452 |
Frequently asked questions
What is Dr. Evelyn Mendoza's medical specialty?
Dr. Evelyn Mendoza practices Specialist in Hemet, CA.
Where does Dr. Evelyn Mendoza practice?
Dr. Evelyn Mendoza practices at 301 N San Jacinto St, Hemet, CA 925433113. Office phone: 9517666460.
What is Dr. Evelyn Mendoza's NPI?
Dr. Evelyn Mendoza's National Provider Identifier (NPI) is 1558368605, issued by NPPES.
Does Dr. Evelyn Mendoza accept Medicare assignment?
Yes. Dr. Evelyn Mendoza accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Evelyn Mendoza commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS J0885); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.